Litigation Details for TAKEDA PHARMACEUTICALS AMERICA, INC. v. APOTEX, INC. (D.N.J. 2021)
✉ Email this page to a colleague
TAKEDA PHARMACEUTICALS AMERICA, INC. v. APOTEX, INC. (D.N.J. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-06-25 |
Court | District Court, D. New Jersey | Date Terminated | 2023-02-07 |
Cause | 35:271 Patent Infringement | Assigned To | Kevin McNulty |
Jury Demand | None | Referred To | Andre M. Espinosa |
Parties | APOTEX, INC. | ||
Patents | 11,192,897; 8,114,874; 8,173,158; 9,493,470 | ||
Attorneys | BRIAN JOHN FORSATZ | ||
Firms | Saiber, LLC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in TAKEDA PHARMACEUTICALS AMERICA, INC. v. APOTEX, INC.
Details for TAKEDA PHARMACEUTICALS AMERICA, INC. v. APOTEX, INC. (D.N.J. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-01-12 | 119 | Opinion | 11,192,897 (the “’897 patent”), and 11,384,086 (the “’086 patent”).1 These patents are directed to crystalline…The patents-in-suit are Patent Nos. 9,493,470 (the “’470 patent”), 11,192,895 (the “’895 patent”), 11,192,897… 63) ’470 Patent = Patent No. 9,493,470 (DE 63-2) ’895 Patent = Patent No. 11,192,895 (DE…, and ’897 patents—was consolidated with Civil Action No. 1:22-cv-06151, a parallel patent infringement…proceedings before the U.S. Patent and Trademark Office that led to approval of the patent, can further illuminate | External link to document |
2021-12-26 | 36 | Answer to Amended Complaint | . Apotex admits that U.S. Patent No. 11,192,897 (the “’897 patent”), issued on December 7, 2021,… As to the Alleged Infringement of U.S. Patent No. 11,192,897 by Apotex …THE PATENTS-IN-SUIT 6. Apotex admits that U.S. Patent No. 9,493,470 (the “’470 patent”), …purports to bring an action for patent infringement under the patent laws of the United States, 35 U.…470 patent. Apotex further admits that what appears to be an uncertified copy of the ’470 patent was | External link to document |
2022-03-31 | 47 | Letter | Claim Construction of U.S. Patent Nos. 9,493,470, 11,192,895, and 11,192,897. (Attachments: # 1 Text of… 2021 8 February 2023 2:21-cv-12998 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |